Image may be NSFW.
Clik here to view.
Clik here to view.
Epizyme Updates Clinical Trial Data on Tazemotostat for Mesothelioma, Other...
Epizyme has reported recent updates from its clinical-stage programs with the company’s lead candidate, tazemotostat, for the treatment of hematological malignancies and genetically defined solid...
View ArticleSelecta Licenses LMB-100 for Combination Tests with SVP-Rapamycin in...
Selecta Biosciences has licensed to use and test the experimental anti-cancer drug LMB-100 from the Center for Cancer Research (CCR) at the National Cancer Institute (NCI). The agreement promotes...
View Article
More Pages to Explore .....
